UTHR - United Therapeutics GAAP EPS of $6.17 beats by $0.51 revenue of $677.7M beats by $53.51M
2024-05-01 06:37:13 ET
More on United Therapeutics
- United Therapeutics: Neutral Stance On Tyvaso's Patent Challenges And Future Growth Prospects
- United Therapeutics Corporation (UTHR) Q4 2023 Earnings Call Transcript
- United Therapeutics Corporation 2023 Q4 - Results - Earnings Call Presentation
- United Therapeutics Q1 2024 Earnings Preview
- Doctors perform first combined heart pump and pig kidney transplant surgery